Zobrazeno 1 - 10
of 300
pro vyhledávání: '"Rafael Ríos"'
Autor:
Noemí Puig, Cristina Agulló, Teresa Contreras, José-Juan Pérez, Irene Aires, María-José Calasanz, Ramón García-Sanz, Sergio Castro, Joaquín Martínez-López, Paula Rodríguez-Otero, Verónica González-Calle, Marta S González, Albert Oriol, Norma C Gutiérrez, Rafael Ríos-Tamayo, Laura Rosiñol, Miguel-Ángel Álvarez, Joan Bargay, Ana-Pilar González-Rodríguez, Adrián Alegre, Fernando Escalante, María-Belén Iñigo, Javier de la Rubia, Ana-Isabel Teruel, Felipe de Arriba, Luis Palomera, Miguel T Hernández, Javier López-Jiménez, Marta Reinoso, Aránzazu García-Mateo, Enrique M Ocio, Joan Bladé, Juan-José Lahuerta, María-Teresa Cedena, Bruno Paiva, Jesús F San Miguel, María-Victoria Mateos
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal gammopathies but no data are yet available in high-risk smoldering myeloma (HRsMM). We have therefore
Externí odkaz:
https://doaj.org/article/c81a444b8f6e434cb89c96b45ea2aec6
Autor:
Rafael Ríos-Tamayo, Juan Alfons Soler, Ricarda García-Sánchez, Ernesto Pérez Persona, Mario Arnao, Antoni García-Guiñón, Abel Domingo, Miriam González-Pardo, Javier de la Rubia, María Victoria Mateos
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: To describe the incorporation of monoclonal antibodies (mAb) in real-world (RW) practice for the treatment of patients with relapsed refractory multiple myeloma (RRMM) in a setting with other treatment alternatives.Methods: This w
Externí odkaz:
https://doaj.org/article/fa57cbe5cfd646a0a1342153e985451e
Publikováno v:
Ingeniería Industrial, Iss 44, Pp 177-203 (2023)
El objetivo del presente trabajo fue evaluar el desempeño de una red de distribución de agua potable. Los datos se obtuvieron por medio del personal del sistema de aguas del municipio en estudio. Se emplearon métricas de capacidad Six Sigma para e
Externí odkaz:
https://doaj.org/article/b2cdd945a4994eb1a63c52d24970298f
Autor:
Rafael Ríos-Tamayo, Ramón Lecumberri, María Teresa Cibeira, Verónica González-Calle, Rafael Alonso, Amalia Domingo-González, Elena Landete, Cristina Encinas, Belén Iñigo, María-Jesús Blanchard, Elena Alejo, Isabel Krsnik, Manuel Gómez-Bueno, Pablo Garcia-Pavia, Javier Segovia-Cubero, Laura Rosiñol, Juan-José Lahuerta, Joaquín Martínez-López, Joan Bladé
Publikováno v:
Cancers, Vol 16, Iss 9, p 1689 (2024)
Systemic AL amyloidosis is a challenging disease for which many patients are considered frail in daily clinical practice. However, no study has so far addressed frailty and its impact on the outcome of these patients. We built a simple score to predi
Externí odkaz:
https://doaj.org/article/16fa2314858449e2bf32a4598b17f427
Publikováno v:
Journal of Water and Health, Vol 21, Iss 5, Pp 601-614 (2023)
Filtration has emerged as a critical technology to reduce waterborne diseases caused by poor water quality. Filtration technology presents key challenges, such as membrane selectivity, permeability and biofouling. Nanomaterials can offer solutions to
Externí odkaz:
https://doaj.org/article/84bfcc034e6445428a49a7365f1e3753
Autor:
Sunil Lakhwani, Laura Rosiñol, Noemí Puig, Miguel-Angel Pico-Picos, Laura Medina-González, Joaquín Martínez-López, Bruno Paiva, María-Teresa Cedena, Albert Oriol, Rafael Ríos-Tamayo, María-Jesús Blanchard, Isidro Jarque, Joan Bargay, José-María Moraleda, Estrella Carrillo-Cruz, Anna Sureda, Isabel Krsnik, Esther González, Luis Felipe Casado, Josep M Martí, Cristina Encinas, Felipe De Arriba, Luis Palomera, Antonia Sampol, Yolanda González-Montes, Cristina Motlló, Javier De La Cruz, Rafael Alonso, María-Victoria Mateos, Joan Bladé, Juan-José Lahuerta, Jesús San-Miguel, Miguel-Teodoro Hernández
Publikováno v:
Haematologica, Vol 109, Iss 6 (2023)
Immunoparesis (IP) in multiple myeloma (MM) patients can be measured by classic assessment of immunoglobulin (Ig) levels or by analysis of the uninvolved heavy/light chain pair of the same immunoglobulin (uHLC) by the Hevylite® assay. In this stu
Externí odkaz:
https://doaj.org/article/cd13fee267b943f2862a37b772331fa1
Autor:
Laura Rosiñol, Benjamin Hebraud, Albert Oriol, Anne-Laurène Colin, Rafael Ríos Tamayo, Cyrille Hulin, María Jesús Blanchard, Denis Caillot, Anna Sureda, Miguel Teodoro Hernández, Bertrand Arnulf, Maria-Victoria Mateos, Margaret Macro, Jesús San-Miguel, Karim Belhadj, Juan José Lahuerta, M. Brigid Garelik, Joan Bladé, Philippe Moreau
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveProviding the most efficacious frontline treatment for newly diagnosed multiple myeloma (NDMM) is critical for patient outcomes. No direct comparisons have been made between bortezomib + lenalidomide + dexamethasone (VRD) and bortezomib + th
Externí odkaz:
https://doaj.org/article/0524dc89aba94458ab67b886bb6cdf83
Autor:
Borja Puertas, Verónica González-Calle, Anna Sureda, María José Moreno, Albert Oriol, Esther González, Laura Rosiñol, Jordi López, Fernando Escalante, Joaquín Martínez-Lopez, Estrella Carrillo, Esther Clavero, Rafael Ríos-Tamayo, Beatriz Rey-Bua, Ana Pilar González-Rodríguez, Victoria Dourdil, Felipe de Arriba, Sonia González, Jaime Pérez-de-Oteyza, Miguel T. Hernández, Aránzazu García-Mateo, Joan Bargay, Joan Bladé, Juan José Lahuerta, Jesús F. San Miguel, Enrique M. Ocio, María-Victoria Mateos
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
In this randomized phase II study (GEM-KyCyDex, clinicaltrials gov. Identifier: NCT03336073), the combination of weekly carfilzomib 70 mg/m2, cyclophosphamide and dexamethasone (KCd) was compared to carfilzomib and dexamethasone (Kd) in relapsed/refr
Externí odkaz:
https://doaj.org/article/a973b16234c247c6bee670237e99afa7
Autor:
José-Ángel Hernández-Rivas, Rafael Ríos-Tamayo, Cristina Encinas, Rafael Alonso, Juan-José Lahuerta
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-23 (2022)
Abstract The increase in the number of therapeutic alternatives for both newly diagnosed and relapsed/refractory multiple myeloma (RRMM) patients has widened the clinical scenario, leading to a level of complexity that no algorithm has been able to c
Externí odkaz:
https://doaj.org/article/6acf35c4898245a69bf0c910bc953aa1
Autor:
Rafael Ríos-Tamayo, Isabel Krsnik, Manuel Gómez-Bueno, Pablo Garcia-Pavia, Javier Segovia-Cubero, Ana Huerta, Clara Salas, Ramona Ángeles Silvestre, Amelia Sánchez, Marta Manso, Laura Delgado, Juan José Lahuerta, Joaquín Martínez-López, Rafael F. Duarte
Publikováno v:
Life, Vol 13, Iss 7, p 1518 (2023)
Monoclonal gammopathies (MGs) are a wide range of diseases that may evolve or progress over time. Comorbidity plays a critical role in this setting. The co-occurrence of two MGs is not a rare event. The evidence on the association of systemic light c
Externí odkaz:
https://doaj.org/article/cf0d6d33e4074c5c81046f64d62afb93